Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC

Clinical trial NCT06863506 · RECRUITING

Trial details

NCT number: NCT06863506
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)

Start date: 2024-10-01
Primary completion: 2027-06-30
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.